CANNABIS LIES Vol. 5: The Gateway Lie

For decades, politicians have claimed marijuana is a gateway to heroin and harder drugs. Federal youth surveys, NSDUH data, and NIDA’s own language tell a different story. Cannabis use is widespread, hard drug use remains rare, and most users do not progress. The data dismantles one of prohibition’s most durable fear narratives.

The Study That Pretends Cannabis Does Nothing

A new cannabis study claims marijuana does nothing for anxiety, depression, or PTSD. The reality is far more complicated. Decades of federal restrictions, limited research access, and synthetic substitutes have shaped the science. This breakdown exposes how incomplete data and selective interpretation continue to drive misleading headlines about cannabis and mental health.

Florida Blocked the 2026 Weed Vote

Florida’s ballot system claims to give voters power, yet the 2026 election cycle shows how procedural barriers can quietly shut the door on citizen initiatives. Signature thresholds, geographic distribution rules, and court challenges blocked every measure from reaching voters, revealing how cannabis legalization fights are often decided by bureaucratic design long before election day.

NY’s Legal Weed Market Is Running Out of Weed

New York legalized cannabis and opened hundreds of stores, but regulators now warn the legal market may not produce enough weed to keep them stocked. With nearly 600 stores open and sales nearing $3 billion, the state is discovering that legalization alone does not guarantee a functioning market.

Cannabis Lies Vol. 3: The Nuisance Lie

Arizona lawmakers are advancing legislation that would criminalize “excessive” marijuana odor detectable across property lines. Cannabis Lie Vol. 3 examines SB 1725 and SCR 1048, the proposed misdemeanor penalties, the legal implications of State v. Sisco, and why critics argue this is a backdoor attempt to reintroduce cannabis criminalization under the banner of nuisance law.

Medical Marijuana and the Paycheck

Workplace Wars continues in New Jersey, where Senate Bill S3452 would protect registered medical cannabis patients from metabolite-only drug test punishment. The proposal shifts the burden to employers, requiring proof by a preponderance of the evidence that lawful medical use caused on-duty impairment, backed by specific articulable symptoms. It also keeps the written notice and three-day explanation or retest process.

Create a website or blog at WordPress.com

Up ↑